GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bridge Biotherapeutics Inc (XKRX:288330) » Definitions » Net Interest Income (for Banks)

Bridge Biotherapeutics (XKRX:288330) Net Interest Income (for Banks)


View and export this data going back to 2019. Start your Free Trial

What is Bridge Biotherapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Bridge Biotherapeutics Business Description

Traded in Other Exchanges
N/A
Address
58, Pangyo - ro, Gyeonggi No. 303, 255 beongil Seas Tower in Bundang Pangyo, Seongnam-si, KOR, 13486
Bridge Biotherapeutics Inc is a drug research and development company. It operates in the pharmaceutical and bio industry. The company has two pipeline clinical-stage products namely, BBT-401 and BBT-877.